Crown Bioscience, Inc. has entered into a strategic partnership with Shin Nippon Biomedical Laboratories (SNBL), a Japan-based company that provides preclinical and clinical drug development services.   SNBL will promote Crown’s translational services to its clients in Japan, and will serve as the exclusive representative for Crown’s services, including its collection of Patient Derived Xenograft (PDX) models.The companies will also look to co-develop new models and services leveraging their res...